ArticleTranslational psychiatry2025

Psilocybin-assisted therapy for treatment-resistant depression in the US: a model-based cost-effectiveness analysis.

Anton L V Avanceña et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.